Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 17 studies | 38% ± 12% | |
plasma cell | 9 studies | 36% ± 12% | |
plasmablast | 6 studies | 36% ± 17% | |
precursor B cell | 3 studies | 25% ± 10% |
Insufficient scRNA-seq data for expression of ST6GALNAC4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1221.63 | 1445 / 1445 | 100% | 32.56 | 183 / 183 |
ovary | 100% | 1993.23 | 180 / 180 | 100% | 47.51 | 430 / 430 |
lung | 100% | 2469.27 | 578 / 578 | 99% | 41.78 | 1146 / 1155 |
thymus | 100% | 1023.74 | 652 / 653 | 99% | 27.63 | 600 / 605 |
pancreas | 100% | 3038.51 | 328 / 328 | 99% | 29.78 | 176 / 178 |
intestine | 100% | 1484.79 | 966 / 966 | 99% | 40.26 | 521 / 527 |
stomach | 100% | 974.19 | 358 / 359 | 99% | 40.71 | 283 / 286 |
uterus | 100% | 1397.84 | 170 / 170 | 98% | 36.34 | 452 / 459 |
brain | 98% | 800.24 | 2599 / 2642 | 100% | 27.92 | 705 / 705 |
kidney | 100% | 1433.52 | 89 / 89 | 96% | 20.38 | 861 / 901 |
breast | 100% | 1378.17 | 459 / 459 | 95% | 31.47 | 1067 / 1118 |
bladder | 100% | 1444.76 | 21 / 21 | 94% | 28.35 | 472 / 504 |
adrenal gland | 100% | 1251.84 | 258 / 258 | 87% | 23.75 | 200 / 230 |
skin | 97% | 1024.05 | 1762 / 1809 | 85% | 19.74 | 399 / 472 |
prostate | 100% | 1171.30 | 245 / 245 | 67% | 7.45 | 336 / 502 |
liver | 50% | 380.15 | 113 / 226 | 56% | 8.89 | 228 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 81.02 | 29 / 29 |
spleen | 100% | 3186.44 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.19 | 1 / 1 |
adipose | 100% | 1519.26 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 2386.63 | 927 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1580.71 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1667.99 | 856 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1081.60 | 798 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 29.05 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 70% | 9.35 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016266 | Biological process | O-glycan processing |
GO_0001574 | Biological process | ganglioside biosynthetic process |
GO_0019082 | Biological process | viral protein processing |
GO_0009311 | Biological process | oligosaccharide metabolic process |
GO_0006664 | Biological process | glycolipid metabolic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0047290 | Molecular function | alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity |
GO_0001665 | Molecular function | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
GO_0008373 | Molecular function | sialyltransferase activity |
Gene name | ST6GALNAC4 |
Protein name | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase (EC 2.4.3.7) (NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc-alpha-2,6-sialyltransferase) (ST6GalNAc IV) (ST6GalNAcIV) (Sialyltransferase 3C) (SIAT3-C) (Sialyltransferase 7D) (SIAT7-D) ST6 (Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4, isoform CRA_b (cDNA FLJ77235, highly similar to Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (ST6GALNAC4), transcript variant 3, mRNA) ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
Synonyms | SIAT3C SIAT7D hCG_2022909 |
Description | FUNCTION: Transfers the sialyl group (N-acetyl-alpha-neuraminyl or NeuAc) from CMP-NeuAc to the GalNAc residue on the NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc sequence of glycoproteins and glycolipids forming an alpha-2,6-linkage. Produces branched type disialyl structures by transfer of a sialyl group onto a GalNAc residue inside the backbone core chains. Prefers O-glycans to glycoproteins or glycolipids. . |
Accessions | A8K7N4 Q9H4F1 ENST00000361444.3 A6NJX0 ENST00000335791.10 |